The 22nd World Congress of Psycho-Oncology & Psychosocial Academy is now accepting abstracts for symposium, oral and poster presentation, to be held in Kyoto, Japan on June 16-19, 2020. The conference theme is “Diversity, Dialogue and Altruism: To achieve universal psychosocial care for all”.
This conference will bring together professionals from multiple health care disciplines to explore, share, learn and discuss the psychosocial aspects of cancer. Participants include researchers, clinicians, educators from cancer centers and other medical centers, patient advocates/patient partners and community-based organizations representing disciplines including medicine, psychiatry, nursing, psychology, social work, spiritual care, nutrition, rehabilitation medicine and occupational health for both adult and pediatric populations.
We invite abstracts on a wide range of topics in cancer care and stages of disease ranging from prevention and early diagnosis, to treatment and survivorship, to palliative and end-of-life care. Submissions can be reports of observational studies and clinical trials, innovative programs and service delivery models, systematic reviews, study protocols, clinical guidelines and best practice and local, regional, national and international approaches to build capacity in research, education and clinical care.
|Call for Abstracts Open Date||October 1, 2019 (10:00 JST)|
|Abstract Submission Deadline||December 2, 2019 (17:00 JST)|
|Abstract Acceptance||March 2, 2020|
*JST = Japan Standard Time
Poster information (including size, title banner, content, and organization requirements) will be provided once Authors have been notified of abstract acceptance. Abstract submissions for poster presentations should follow the prescribed clinical or research format (see below). At least one author of accepted poster abstracts must be present at their posters during an assigned session to allow for dialogue with participants. Poster sessions may run concurrently with other Symposium sessions.
consist of 5-minute presentations followed by 5-minute Q/A’s. Grouped with other like presentations, this format is best suited for recently started projects or projects (Clinical or Research) being contemplated. This is a great option for attendees who want to present their study protocol/preliminary results or trainees who seek feedback on their research proposal/preliminary results. Abstract submissions for rapid oral presentations should follow the prescribed clinical or research format. Abstracts should include 2 – 3 questions for which authors are seeking feedback.
20-minute presentations are best suited for completed work. Abstract submission for clinical or research presentations are welcome. Presenters should plan for 15-minute presentations and five minutes for Q&A. Abstracts for consideration as oral presentations must follow the format specified below under the “Abstract Type” section. Submitting authors must specify the abstract theme under which the work is to be considered.
60-90 minutes symposiums consist of 3-4 oral theme-focused abstract presentations facilitated by a discussion led by a moderator. The symposium submission will take the format of one Chairperson (submitting author) who will act as the moderator, with 3-4 presenters in total. The symposium submission will consist of one summary abstract which overviews the symposium theme and the 3-4 individual detailed abstracts, one for each proposed presentation. The entire symposium presentation will be 60-90 minutes in total. Individual symposiums abstracts can follow either the “clinical” or “research” format.Steps:
Symposium abstracts that appeal to an international/cross-cultural audience will be given highest priority.
The official language of IPOS 2020 is English.
While IPOS also allow a few presentations to be conducted in other than English, authors who wish to present in other language should indicate their preference during abstract submission, amendment after abstract submission is not allowed.
Please be aware that all abstract text and presentation material should be in English for all presenters.
Abstracts will be accepted for the following themes:
|1||Access, Inequity and Diversity|
|2||Advance Care Planning|
|8||Culture, Sex/gender and Underserved population|
|17||Family and Bereaved family|
|18||Fear and anxiety|
|21||Implementation science/ Knowledge translation|
|23||Low resource setting|
|24||Medical staff and Clinician|
|28||Palliative & supportive care|
|31||Primary, Secondary and Tertiary cancer prevention|
|33||Public health and Community based organization|
|36||Symptom, Late effect|
The clinical stream refers to items such as development of innovative programs or interventions/service delivery/model of care.
Word Limit: 250 words.
The research stream refers to work that is primarily based on the scientific method of discovery of hypothesis testing or theory development. This stream can include work from protocols, to review and studies of various design.
Word Limit: 250 words.
Prior to submitting an abstract, please make sure that you have the following information available:
Name, City and Affiliation of all authors
Biographies for presenting author
Abstract submission is in text format only. Abstracts must be submitted under one of the pre-defined topics and type must be indicated. Upon submission a confirmation will be emailed to the email of the account holder. This confirmation is a confirmation of abstract submission and NOT a notice of acceptance.
Abstracts will be judged solely on the data submitted.
Statements such as "further data will be presented" are not acceptable and will result in the abstract being rejected.
The IPOS 2020 Scientific Committee will select abstract for orals, poster and symposium presentations by March 2, 2020. The submitting author will receive an email with the decision of the scientific committee. If a selected author cannot attend, the presenting author should assign a replacement. The Scientific Committee reserves the right to reallocate abstracts as necessary. All presenting authors must register for the full conference.
For abstract enquiries, please contact